Leukemia/ Lymphoma Program
Our team of physicians, nurse practitioner, nurses, social workers, clinical research assistants, pharmacists and scientists provides compassionate clinical care and treatments through research and clinical trials.
The Leukemia/Lymphoma Program sees children with the following conditions:
• Acute lymphoblastic (lymphoblastic) leukemia (ALL)
• Acute myelogenous (myeloblastic) leukemia (AML)
• Anaplastic large cell lymphoma (ALCL)
• Hodgkin lymphoma
• Infant leukemia
• Non-Hodgkin lymphoma
Research to Improve Patient Care and Outcomes
We want to see out patients thrive and help families cope with their child’s illness. The program participates in clinical trials sponsored by cooperative groups that study novel treatments for childhood leukemia and lymphoma, including the Children’s Oncology Group (COG) supported by the National Cancer Institute.
As a result, Children’s leukemia and lymphoma patients have access to the most current therapies in the treatment of pediatric cancers. Children’s National is the regions only site approved for Phase I clinical trials. The Leukemia/Lymphoma Program currently treats more than 50 new patients a year and follows approximately 200 patients participating in clinical trials.
Support for Children’s Families
Our work revolves around children and we are sensitive to their needs as well as those of their families. The Center for Cancer and Blood Disorders established the Patient and Family Support Program to provide comprehensive mental health and psychosocial services and helpful resources for all patients as well as parents and siblings.
Children’s National also created the Parent’s Letter Project as a way for parents to support each other by sharing their personal stories. When you can relate to someone who has been through a similar experience, you can learn more about what to expect and how to deal with difficult times.
Back to Top - Departments & Programs - Children's National Medical Center